Each year, ADDF attendees hear from industry-leaders like Harvey Berger (Arena BioWorks) and Jennifer Petter (Arrakis Therapeutics) as they share lessons shaping drug development’s future.
"Big ideas deserve bold conversations, and ADDF sessions deliver both! Looking forward to another year where brilliant ideas meet sharper questions. Brains, boundary-pushing perspectives, and transparent sharing — what’s not to love?"
A rare, candid conversation with Harvey Berger on building—and rebuilding—
companies at the cutting edge of science. From pioneering cancer therapies
to shaping the next generation of biotech leadership, his journey will
inspire, challenge, and equip you to think bigger about what’s possible
in drug development.
Expect hard-won lessons on leading through uncertainty, aligning teams
through pivots, and developing leaders who can scale ideas from concept
to clinic.
Harvey Berger,
Chairman and Chief Executive Officer of Arena BioWorks, LLC